Comparison of SMS, IVR, and CATI Surveys in Colombia

NCT ID: NCT04506931

Last Updated: 2022-04-26

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

5676 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-01-15

Study Completion Date

2021-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of the study is to adapt and assess the feasibility, quality, and validity of short message service or 'text message' (SMS), interactive voice response (IVR), and computer assisted telephone interviews (CATI) for collecting information on noncommunicable disease (NCD) risk factors

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Using random digit dialing (RDD) sampling technique, RDD participants will be randomized to one of the three arms: 1) SMS or 2) IVR or 3) CATI. Participants in the first study arm will receive an SMS survey. Participants in the second study arm will receive a IVR survey. Participants in the third study arm will receive a CATI survey. The IVR, SMS and CATI questionnaires contain a set of demographic questions and one NCD module (alcohol, or tobacco, or diet, or physical activity, or blood pressure and diabetes). The investigators will examine contact, response, refusal and cooperation rates and demographic representativeness by each study arm.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Surveys and Questionnaires Noncommunicable Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants were randomized to one of three mobile phone survey modalities: 1) SMS; 2) IVR; 3) CATI.
Primary Study Purpose

OTHER

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Short Message Service (SMS) survey

Participants will receive an SMS survey

Group Type EXPERIMENTAL

SMS Survey

Intervention Type OTHER

Participants will receive a SMS survey

Interactive Voice Response (IVR) survey

Participants will receive an IVR survey

Group Type EXPERIMENTAL

IVR Survey

Intervention Type OTHER

Participants will receive an IVR survey

Computer Assisted Telephone Interviews (CATI) survey

Participants will receive a CATI survey

Group Type EXPERIMENTAL

CATI Survey

Intervention Type OTHER

Participants will receive a CATI survey

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SMS Survey

Participants will receive a SMS survey

Intervention Type OTHER

IVR Survey

Participants will receive an IVR survey

Intervention Type OTHER

CATI Survey

Participants will receive a CATI survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Access to a mobile phone
* Greater or equal to 18 years of age
* In Colombia, conversant in the Spanish language

Exclusion Criteria

* Less than 18 years of age
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Pontificia Universidad Javeriana

OTHER

Sponsor Role collaborator

Johns Hopkins Bloomberg School of Public Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dustin Gibson, PhD

Role: PRINCIPAL_INVESTIGATOR

Johns Hopkins University Bloomberg School of Public Health

Angelica T Quinterro, PhD, MD, MSc

Role: PRINCIPAL_INVESTIGATOR

Pontificia Universidad Javeriana

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Pontificia Universidad Javeriana

Bogotá, , Colombia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Colombia

References

Explore related publications, articles, or registry entries linked to this study.

Gibson DG, Pariyo GW, Wosu AC, Greenleaf AR, Ali J, Ahmed S, Labrique AB, Islam K, Masanja H, Rutebemberwa E, Hyder AA. Evaluation of Mechanisms to Improve Performance of Mobile Phone Surveys in Low- and Middle-Income Countries: Research Protocol. JMIR Res Protoc. 2017 May 5;6(5):e81. doi: 10.2196/resprot.7534.

Reference Type BACKGROUND
PMID: 28476729 (View on PubMed)

Gibson DG, Pereira A, Farrenkopf BA, Labrique AB, Pariyo GW, Hyder AA. Mobile Phone Surveys for Collecting Population-Level Estimates in Low- and Middle-Income Countries: A Literature Review. J Med Internet Res. 2017 May 5;19(5):e139. doi: 10.2196/jmir.7428.

Reference Type BACKGROUND
PMID: 28476725 (View on PubMed)

Gibson DG, Farrenkopf BA, Pereira A, Labrique AB, Pariyo GW. The Development of an Interactive Voice Response Survey for Noncommunicable Disease Risk Factor Estimation: Technical Assessment and Cognitive Testing. J Med Internet Res. 2017 May 5;19(5):e112. doi: 10.2196/jmir.7340.

Reference Type BACKGROUND
PMID: 28476724 (View on PubMed)

Hyder AA, Wosu AC, Gibson DG, Labrique AB, Ali J, Pariyo GW. Noncommunicable Disease Risk Factors and Mobile Phones: A Proposed Research Agenda. J Med Internet Res. 2017 May 5;19(5):e133. doi: 10.2196/jmir.7246.

Reference Type BACKGROUND
PMID: 28476722 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00007318 - xyz

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.